FDA Inspection 985599 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on October 3, 2016 in Jayuya, PR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 3, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jayuya, PR (United States)